<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Lactational mastitis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Lactational mastitis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Lactational mastitis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            J Michael Dixon, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Adetola Louis-Jacques, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anees B Chagpar, MD, MSc, MA, MPH, MBA, FACS, FRCS(C)
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel J Sexton, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sandra Nelson, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Keri K Hall, MD, MS
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen Eckler, MD, FACOG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 05, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lactational mastitis is inflammation of the breast tissues associated with breastfeeding. Mastitis can occur any time during lactation but is most common in the first four to six weeks of breastfeeding. Nipple injury appears to be an inciting factor, although the exact mechanisms are debated. Lactational mastitis is characterized by localized pain, swelling and, often, redness. In some patients, the initial inflammatory process leads to bacterial infection, which may result in fever and malaise. Bacterial infection can progress to local abscess formation if not treated promptly.
        </p>
        <p>
         Issues, etiology, diagnosis, and treatment of lactational mastitis will be reviewed here. General issues related to lactation and discussions of other breast infections are presented separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4986.html" rel="external">
          "Initiation of breastfeeding"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4978.html" rel="external">
          "Breastfeeding: Parental education and support"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/795.html" rel="external">
          "Primary breast abscess"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         In this topic, when discussing study results, we will use the terms "woman/en" or "patient(s)" as they are used in the studies presented. We encourage the reader to consider the specific counseling and treatment needs of transgender and gender-expansive individuals.
        </p>
        <p class="headingAnchor" id="H3755840378">
         <span class="h1">
          EPIDEMIOLOGY AND PATHOGENESIS
         </span>
        </p>
        <p class="headingAnchor" id="H289639399">
         <span class="h2">
          Epidemiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lactational mastitis has been estimated to occur in 2 to 20 percent of breastfeeding patients [
         <a href="#rid1">
          1-3
         </a>
         ]. Meta-analysis of pooled incidence data from three studies reported 11.1 episodes per 1000 breastfeeding weeks (95% CI 10.2-12.0) from birth to postpartum week 25 [
         <a href="#rid2">
          2
         </a>
         ]. Episodes are most common in the first four to six weeks of breastfeeding [
         <a href="#rid2">
          2
         </a>
         ]. The incidence of mastitis requiring hospitalization is low; in one cohort including 136,459 new mothers, 127 patients were hospitalized for mastitis, an incidence of 9 per 10,000 deliveries [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         The risk of recurrence of mastitis in individuals with prior history of lactational mastitis is higher than in patients with no prior history. (See
         <a class="local">
          'Recurrence'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3675670494">
         <span class="h2">
          Pathogenesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pathogenesis of lactational mastitis is not well defined as the disease represents a spectrum of conditions and may include poorly understood interactions between the mammary-associated microbiota and host-specific genetic factors [
         <a href="#rid5">
          5,6
         </a>
         ]. Breastfeeding factors, including nipple trauma, breastfeeding challenges, and hyperlactation appear to contribute to its development [
         <a href="#rid6">
          6
         </a>
         ]. The roles of dysbiosis and breast pump use are debated [
         <a href="#rid6">
          6,7
         </a>
         ].
        </p>
        <p>
         Lactational mastitis follows ductal narrowing that can develop in response to a variety of factors; the ductal narrowing then results in poor milk drainage from the part of the breast drained by the affected duct. Milk stasis that persists beyond 12 to 24 hours is believed to be an inciting factor for bacterial growth and resultant infectious mastitis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cascade of events
         </strong>
         – The primary event appears to be ductal narrowing  (
         <a class="graphic graphic_figure graphicRef88523" href="/z/d/graphic/88523.html" rel="external">
          figure 1
         </a>
         ). Duct narrowing leads to poor milk drainage. Resultant swelling can lead to inflammation, edema, and compression of additional milk ducts. If the ductal narrowing persists, stagnant milk can become infected with bacteria, and this infection can spread into the surrounding breast tissue, resulting in infectious mastitis, and, in some patients, abscess  (
         <a class="graphic graphic_figure graphicRef68275" href="/z/d/graphic/68275.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Associated risk factors
         </strong>
         – Lactational mastitis often occurs in the setting of breastfeeding challenges that may contribute to problems with milk drainage [
         <a href="#rid6">
          6
         </a>
         ]. Its etiology is complex and risk factors include [
         <a href="#rid2">
          2,5
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Breastfeeding difficulties (see
         <a class="medical medical_review" href="/z/d/html/4996.html" rel="external">
          "Common problems of breastfeeding and weaning"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Nipple injury, including excoriation or cracking (see
         <a class="medical medical_review" href="/z/d/html/4996.html" rel="external">
          "Common problems of breastfeeding and weaning", section on 'Nipple injury'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Breast pump use (see
         <a class="medical medical_review" href="/z/d/html/4986.html" rel="external">
          "Initiation of breastfeeding", section on 'Milk expression'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hyperlactation (see
         <a class="medical medical_review" href="/z/d/html/4996.html" rel="external">
          "Common problems of breastfeeding and weaning", section on 'Milk overproduction'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of mastitis (See
         <a class="local">
          'Recurrence'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3501752601">
         <span class="h2">
          Microbiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most episodes of bacterial lactational mastitis are caused by
         <em>
          Staphylococcus aureus
         </em>
         , followed by streptococci
         <em>
         </em>
         species
         <em>
         </em>
         [
         <a href="#rid8">
          8-12
         </a>
         ]. There is no evidence that yeast plays an important part in infection or nipple pain associated with breast feeding [
         <a href="#rid13">
          13,14
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevalence of Staph and Strep
         </strong>
         – In one study comparing milk from 192 patients with mastitis with milk from 466 unaffected donors,
         <em>
          S. aureus
         </em>
         and group B Streptococci were recovered significantly more frequently from patients with mastitis (
         <em>
          S. aureus
         </em>
         45 versus 31 percent and Group B streptococci 21 versus 10 percent) [
         <a href="#rid8">
          8
         </a>
         ]. That 31 percent of patients without mastitis also had
         <em>
          S. aureus
         </em>
         in their milk highlights the limits of solely using milk culture for diagnosing mastitis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Impact of MRSA
         </strong>
         – Methicillin-resistant
         <em>
          S. aureus
         </em>
         (MRSA) has become an important pathogen in cases of lactational mastitis [
         <a href="#rid1">
          1,12,15
         </a>
         ]. In one study of 127 patients hospitalized for mastitis, MRSA was the most common pathogen isolated from women with mastitis alone (24 of 54 specimens) or mastitis and abscess (18 of 27 specimens) [
         <a href="#rid15">
          15
         </a>
         ]. In a different study of 535 lactating patients (316 with infectious mastitis and 219 with breast abscess), 70 patients (34.5 percent) had MRSA [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Less common
         </strong>
         – Less frequent pathogens include
         <em>
          Streptococcus pyogenes
         </em>
         (group A or B),
         <em>
          Escherichia coli
         </em>
         ,
         <em>
          Bacteroides
         </em>
         species,
         <em>
          Corynebacterium
         </em>
         species, and coagulase-negative staphylococci (eg,
         <em>
          Staphylococcus lugdunensis
         </em>
         ) [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H725874348">
         <span class="h2">
          Risk reduction
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of developing lactational mastitis can be reduced by frequent on-demand feeding (or milk expression) and by optimizing breastfeeding technique [
         <a href="#rid16">
          16
         </a>
         ]. Breastfeeding education and light breast massage may be helpful, but supporting data are of limited quality [
         <a href="#rid17">
          17,18
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4986.html" rel="external">
          "Initiation of breastfeeding", section on 'Principles of breastfeeding'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lactational mastitis presents on a clinical spectrum ranging from early, focal disease to, in rare cases, systemic illness.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lactational mastitis
         </strong>
         – Patients with lactational mastitis typically present with a swollen and tender region of the breast that may also be red (ie, erythematous)  (
         <a class="graphic graphic_picture graphicRef126606" href="/z/d/graphic/126606.html" rel="external">
          picture 1
         </a>
         ) [
         <a href="#rid5">
          5,19
         </a>
         ]. Lactational mastitis is most common in the first three months of breastfeeding. The erythema and induration can progress beyond the initial quadrant and effect the entire breast. Systemic symptoms such as fever, chills, and tachycardia may be present. Patients with symptoms lasting more than 24 hours should be evaluated. (See
         <a class="local">
          'Diagnostic evaluation'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infectious lactational mastitis
         </strong>
         – Patients with infectious lactational mastitis typically present with a firm, red, painful, swollen area of one breast associated with fever &gt;38.3ºC; milk secretion can be diminished. Systemic complaints may include myalgia, chills, malaise, and flu-like symptoms. Rarely, patients with severe mastitis can develop sepsis. (See
         <a class="medical medical_review" href="/z/d/html/1657.html" rel="external">
          "Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sepsis from advanced infection
         </strong>
         – Rarely, patients with severe infectious lactational mastitis can develop symptoms of sepsis, including hypotension, tachycardia, tachypnea, fever, leukocytosis, and/or evidence of end organ dysfunction. These patients require immediate evaluation and resuscitative management, as discussed in detail elsewhere.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1657.html" rel="external">
          "Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1613.html" rel="external">
          "Evaluation and management of suspected sepsis and septic shock in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2742588205">
         <span class="h1">
          DIAGNOSTIC EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H119195250">
         <span class="h2">
          History and physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lactational mastitis is diagnosed by physical examination confirming a swollen and tender breast in a lactating patient with history of breast pain and/or swelling  (
         <a class="graphic graphic_picture graphicRef126606" href="/z/d/graphic/126606.html" rel="external">
          picture 1
         </a>
         ). Red coloration may be present but is not required for the diagnosis; red coloration may be absent in patients with darker skin tone until later in the process. In the early stages, the presentation can be subtle with few clinical signs. Low-grade fever may be present. Laboratory tests and imaging studies are not indicated for the diagnosis of lactational mastitis.
        </p>
        <p>
         Patients with bacterial infection generally present with a large area of breast swelling with overlying skin erythema and fever &gt;38.3°C. Reactive axillary lymphadenopathy may be associated with axillary pain and swelling. Systemic complaints may include myalgia, chills, malaise, and flu-like symptoms. Rarely, patients may have evidence of sepsis  (
         <a class="graphic graphic_table graphicRef79464" href="/z/d/graphic/79464.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H1609233613">
         <span class="h2">
          Laboratory evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         While routine laboratory tests are not helpful for diagnosing lactational mastitis, cultures can be helpful for patients with suspected bacterial infection, infection that does not respond to initial treatment, or patients with evidence of sepsis  (
         <a class="graphic graphic_table graphicRef79464" href="/z/d/graphic/79464.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Milk culture
         </strong>
         – While not done routinely, culture of the breast milk can be useful to guide selection of antibiotics. Culture can be helpful in the setting of infection that is particularly severe, hospital acquired, or unresponsive to initial empiric antibiotics [
         <a href="#rid16">
          16,20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         To perform breast milk culture, the nipple and areola are cleaned with either topical antiseptic or washed with soap and water [
         <a href="#rid5">
          5
         </a>
         ]. After sterile gloves are donned, milk is expressed from the breast into a sterile collection tube without having the breast and tube connect. Approximately 5 to 10 mL of milk is collected and labeled as "body fluid culture."
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Blood culture
         </strong>
         – Blood cultures are warranted in the setting of severe infection (eg, hemodynamic instability, progressive erythema) but are otherwise not routinely necessary.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2651703172">
         <span class="h2">
          Imaging studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Imaging studies are useful if lactational mastitis does not respond within 48 to 72 hours to supportive care and/or antibiotics. Ultrasound is the most effective method of differentiating mastitis from breast abscess [
         <a href="#rid21">
          21-25
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/795.html" rel="external">
          "Primary breast abscess"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of abnormalities of the lactating breast include engorgement, plugged ducts, galactocele, abscess, and, rarely, cancer. The differential diagnosis of mastitis unrelated to lactation is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/794.html" rel="external">
          "Nonlactational mastitis in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Engorgement
         </strong>
         – Engorgement occurs due to interstitial edema with onset of lactation or, at other times, with accumulation of excess milk. Postpartum engorgement is physiologic bilateral breast fullness that generally occurs on postpartum days three to five [
         <a href="#rid26">
          26,27
         </a>
         ]; onset may be one to two days later for patients who undergo cesarean delivery [
         <a href="#rid26">
          26
         </a>
         ]. Secretion of mature milk is believed to distend the alveolar ducts, which results in vascular and lymphatic compression. Typical symptoms are bilaterally full and tense breasts which may be painful. Some patients experience "flu-like" malaise as well. Symptoms are self-limited and generally improve in 24 hours. (See
         <a class="medical medical_review" href="/z/d/html/6711.html" rel="external">
          "Overview of the postpartum period: Normal physiology and routine maternal care"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Multiple treatments have been studied, but efficacy has not been established [
         <a href="#rid28">
          28
         </a>
         ]. Care is generally supportive. For patients with persistent symptoms, we advise meeting with a lactation specialist, wearing a supportive breast-feeding bra that does not constrict, and using
         <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">
          ibuprofen
         </a>
         or
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         as needed for discomfort. (See
         <a class="medical medical_review" href="/z/d/html/6711.html" rel="external">
          "Overview of the postpartum period: Normal physiology and routine maternal care", section on 'Management of breast engorgement and lactation suppression'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Severe engorgement may be distinguished from mastitis in that engorgement is bilateral with generalized involvement while mastitis is localized and generally affects only one breast [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4996.html" rel="external">
          "Common problems of breastfeeding and weaning", section on 'Engorgement'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Focal duct narrowing (
         </strong>
         "
         <strong>
          Plugged duct
         </strong>
         "
         <strong>
          )
         </strong>
         – "Plugged ducts" are localized areas of congested mammary tissue  (
         <a class="graphic graphic_picture graphicRef133164" href="/z/d/graphic/133164.html" rel="external">
          picture 2
         </a>
         ). These can be mistaken for infection. (See
         <a class="medical medical_review" href="/z/d/html/4996.html" rel="external">
          "Common problems of breastfeeding and weaning"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4996.html" rel="external">
          "Common problems of breastfeeding and weaning", section on 'Ductal narrowing'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Breast abscess
         </strong>
         – Roughly 3 to 11 percent of patients with lactational mastitis will progress to an infected fluid collection (ie, abscess) [
         <a href="#rid29">
          29
         </a>
         ]. Physical examination findings suggestive of abscess include a palpable, tender, and well-defined fluctuant area of the breast; the skin may or may not be compromised  (
         <a class="graphic graphic_picture graphicRef74709 graphicRef68502" href="/z/d/graphic/74709.html" rel="external">
          picture 3A-B
         </a>
         ) [
         <a href="#rid5">
          5
         </a>
         ]. Ultrasonography may aid in diagnosis and facilitate guided drainage (preferred treatment)  (
         <a class="graphic graphic_diagnosticimage graphicRef62711" href="/z/d/graphic/62711.html" rel="external">
          image 1
         </a>
         ) [
         <a href="#rid5">
          5,21,24,25,30
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/795.html" rel="external">
          "Primary breast abscess"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Galactocele
         </strong>
         – A galactocele (also known as a milk retention cyst) is a cystic collection of fluid that is usually caused by obstructed or narrowed milk ducts [
         <a href="#rid31">
          31
         </a>
         ]. Galactoceles present as soft cystic masses  (
         <a class="graphic graphic_picture graphicRef70540" href="/z/d/graphic/70540.html" rel="external">
          picture 4
         </a>
         ); they are not tender and are not associated with systemic manifestations. Ultrasonography may demonstrate a simple milk cyst or a complex mass  (
         <a class="graphic graphic_diagnosticimage graphicRef65929" href="/z/d/graphic/65929.html" rel="external">
          image 2
         </a>
         ). The diagnosis can be made on the basis of the clinical history and ultrasound examination. Occasionally, needle aspiration may be used for diagnosis, which yields a milky substance. (See
         <a class="medical medical_review" href="/z/d/html/4996.html" rel="external">
          "Common problems of breastfeeding and weaning", section on 'Galactocele'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inflammatory breast cancer
         </strong>
         – Inflammatory breast cancer (IBC) should be considered if mastitis does not resolve with appropriate treatment. Erythema may improve to some degree with antibiotics in patients with IBC, but there are usually other manifestations of IBC present; IBC may be differentiated from mastitis by clinical manifestations of skin thickening due to edema, erythema, and peau d'orange appearance  (
         <a class="graphic graphic_picture graphicRef70894 graphicRef65383" href="/z/d/graphic/70894.html" rel="external">
          picture 5A-B
         </a>
         ). It is often associated with palpable axillary lymphadenopathy due to metastatic nodal involvement. The diagnosis is established with core biopsy. (See
         <a class="medical medical_review" href="/z/d/html/768.html" rel="external">
          "Inflammatory breast cancer: Clinical features and treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          TREATMENT
         </span>
        </p>
        <p class="headingAnchor" id="H15694998">
         <span class="h2">
          Clinical management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Physiological breastfeeding and anti-inflammatory measures are the key interventions to resolve ductal narrowing and prevent bacterial mastitis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Candidates
         </strong>
         –
         <strong>
          All
         </strong>
         patients with lactational mastitis should be educated about this approach, even if additional treatment with antibiotics is warranted. Patients who are candidates for clinical management only include those with focal breast findings and mild systemic symptoms. Improvement should be seen within 24 to 48 hours.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Approach
         </strong>
         – Initial management of nonsevere lactational mastitis consists of several interventions aimed at relieving pain and maintaining milk flow through the milk ducts of the breast [
         <a href="#rid32">
          32
         </a>
         ]. We provide the following guidance to patients [
         <a href="#rid5">
          5,10,11,16,19,20,22,32,33
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Feed the infant on cue or express the volume of milk that the child needs.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Minimize breast pump usage if possible and avoid use of nipple shields.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For pain relief:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Topical – Warm or cold compresses (ie, soak a cloth in warm or cold water and place it on the breast). While use of either heat or cold may reduce pain, applying cold may decrease associated tissue edema and inflammation [
         <a href="#rid5">
          5
         </a>
         ]. Supporting data for both interventions are limited [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Systemic –
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          Acetaminophen
         </a>
         or
         <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">
          ibuprofen
         </a>
         can be used to relieve pain and reduce inflammation and fever (
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         should be avoided [
         <a href="#rid32">
          32
         </a>
         ]).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Rest and drink plenty of fluids.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Avoid deep massage (light sweeping of the skin similar to that for manual lymphatic drainage may be helpful [
         <a href="#rid34">
          34,35
         </a>
         ]).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Wear an appropriately fitting supportive bra (ie, not too tight).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Keep patients and infants together if feasible.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Unclear benefit of probiotics
         </strong>
         – Data on the use of probiotic use to treat or prevent mastitis are inconsistent. Two different reviews were unable to make definitive recommendations due to the limitations of available trials and low quality of evidence [
         <a href="#rid17">
          17,36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Warning signs for bacterial infection
         </strong>
         – If symptoms persist beyond 24 to 48 hours or are accompanied by fever or systemic symptoms, treatment additionally includes antibiotic therapy with activity against
         <em>
          S. aureus
         </em>
         [
         <a href="#rid11">
          11,13,19,21,22,36,37
         </a>
         ]. (See
         <a class="local">
          'Antibiotic therapy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Antibiotic therapy
         </span>
        </p>
        <p class="headingAnchor" id="H2250687193">
         <span class="h3">
          Approach and patient counseling
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antibiotic use is reserved for patients with evidence of bacterial infection. This reflects a change from the historical approach of starting antibiotics quickly for all patients with lactational mastitis [
         <a href="#rid19">
          19
         </a>
         ]. If available, milk culture results can guide antibiotic selection. Infection can progress to local abscess formation if not treated promptly.
        </p>
        <p>
         Antibiotic treatment is given in addition to the clinical approach above. In one observational study, when infectious lactational mastitis was treated with a combination of antibiotics and breast emptying, the rate of symptom resolution within two weeks increased from 50 to 96 percent [
         <a href="#rid10">
          10
         </a>
         ]. Thus, continued breast feeding should be encouraged in the presence of infective lactational mastitis, including abscess [
         <a href="#rid16">
          16,38,39
         </a>
         ]. (See
         <a class="local">
          'Clinical management'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H3843955301">
         <span class="h3">
          Antibiotic selection
         </span>
         <span class="headingEndMark">
          —
         </span>
         As high quality data specific to treatment of infectious mastitis are limited [
         <a href="#rid33">
          33
         </a>
         ], treatment is based on that for cellulitis and other soft tissue infections  (
         <a class="graphic graphic_algorithm graphicRef139109" href="/z/d/graphic/139109.html" rel="external">
          algorithm 1
         </a>
         ). Empiric therapy should include activity against
         <em>
          S. aureus
         </em>
         [
         <a href="#rid10">
          10,33
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">
          "Acute cellulitis and erysipelas in adults: Treatment", section on 'Acute cellulitis'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nonsevere infection
         </strong>
         – Patients with nonsevere disease are treated based on their risk factors for methicillin-resistant
         <em>
          S. aureus
         </em>
         (MRSA)  (
         <a class="graphic graphic_table graphicRef53504" href="/z/d/graphic/53504.html" rel="external">
          table 2
         </a>
         ). Nonsevere disease includes patients with typical clinical signs of infectious mastitis (eg, pain, redness, fever, myalgia) who are hemodynamically stable, immunocompetent, and have not previously been treated with antibiotics for mastitis. Drug selection is based on availability, cost, patient allergies and prior treatment response (if applicable), culture results (if available), and local antibiotic resistance patterns. (See
         <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">
          "Acute cellulitis and erysipelas in adults: Treatment", section on 'Selecting an antibiotic regimen'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Nonsevere without MRSA risk factors
         </strong>
         – Patients without MRSA risk factors are offered  (
         <a class="graphic graphic_algorithm graphicRef139109" href="/z/d/graphic/139109.html" rel="external">
          algorithm 1
         </a>
         ) [
         <a href="#rid5">
          5,33
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <a class="drug drug_general" data-topicid="9349" href="/z/d/drug information/9349.html" rel="external">
          Dicloxacillin
         </a>
         500 mg orally four times daily.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <strong>
          Or
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Flucloxacillin 500 mg orally four times daily.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <strong>
          Or
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">
          Cephalexin
         </a>
         500 mg orally four times daily.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         For patients with beta-lactam hypersensitivity, options include antibiotics that are often used for MRSA infections, as described below (eg,
         <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">
          trimethoprim-sulfamethoxazole
         </a>
         ,
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Nonsevere with MRSA risk factors
         </strong>
         – In the setting of nonsevere infection with risk for MRSA  (
         <a class="graphic graphic_table graphicRef53504" href="/z/d/graphic/53504.html" rel="external">
          table 2
         </a>
         ), effective oral antibiotics compatible with lactating patients include  (
         <a class="graphic graphic_table graphicRef64178" href="/z/d/graphic/64178.html" rel="external">
          table 3
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">
          Trimethoprim-sulfamethoxazole
         </a>
         (TMP-SMX; 1 double-strength tablet orally twice daily).
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         TMP-SMX may be used in patients who are breastfeeding healthy, full-term infants who are at least one month old. The drug should be avoided in patients who are breastfeeding newborn infants (&lt;1 month old) or infants with glucose-6-phosphate dehydrogenase deficiency, and it should be used cautiously in patients who are breastfeeding infants who are jaundiced, premature, or ill [
         <a href="#rid37">
          37
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/493.html" rel="external">
          "Trimethoprim-sulfamethoxazole: An overview", section on 'Pregnancy and breastfeeding'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <strong>
          Or
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          Clindamycin
         </a>
         450 mg orally three times daily.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          Clindamycin
         </a>
         has been associated with
         <em>
          Clostridioides difficile
         </em>
         colitis and increasing rates of resistance among staphylococci. (See
         <a class="medical medical_review" href="/z/d/html/2696.html" rel="external">
          "
          <i>
           Clostridioides difficile
          </i>
          infection in adults: Epidemiology, microbiology, and pathophysiology", section on 'Antibiotic use'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Severe infection
         </strong>
         – Patients with severe infection (eg, fever, hypotension, tachycardia), rapid expansion of infection, or infection that progresses despite appropriate oral antibiotics warrant intravenous treatment that provides coverage of both Gram-positive and Gram-negative organisms. In this scenario, intravenous antibiotics are typically given in an inpatient setting. (See
         <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">
          "Acute cellulitis and erysipelas in adults: Treatment", section on 'Indications for parenteral therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We use the following initial approach:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Initial empiric inpatient therapy with intravenous
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         (
         <a class="graphic graphic_table graphicRef128911" href="/z/d/graphic/128911.html" rel="external">
          table 4
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <strong>
          Plus
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Either
         <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">
          ceftriaxone
         </a>
         (2 g intravenously once daily)
         <strong>
          or
         </strong>
         <a class="drug drug_general" data-topicid="9777" href="/z/d/drug information/9777.html" rel="external">
          piperacillin-tazobactam
         </a>
         (3.375 g intravenously every six hours).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         If beta-lactam agents are not an option,
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         can be combined with an aminoglycoside (eg,
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         ). Aminoglycosides are used in this setting because of their safety in breastfeeding. Dosing is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/475.html" rel="external">
          "Dosing and administration of parenteral aminoglycosides"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Subsequent drug selection should be tailored to culture and sensitivity results from breast milk and/or blood cultures.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evidence of sepsis
         </strong>
         – Patients with evidence of sepsis, including fever, hypotension, tachycardia, tachypnea, leukocytosis, and/or evidence of end organ dysfunction, require immediate evaluation and management with resuscitative therapy. The management of patients with suspected sepsis is presented in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/1613.html" rel="external">
          "Evaluation and management of suspected sepsis and septic shock in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H606390276">
         <span class="h3">
          Duration of treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         The optimal duration of antibiotic treatment is not clear and varies, in part, by severity of initial disease and speed of patient response. Treatment durations are extrapolated from other types of cellulitis. (See
         <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">
          "Acute cellulitis and erysipelas in adults: Treatment", section on 'Duration of antibiotic therapy'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nonsevere infection
         </strong>
         – In general, patients with uncomplicated infection respond fully within five to six days of oral antibiotics. Symptomatic improvement is typically seen within 24 to 48 hours. Patients who do not respond fully may require additional antibiotic treatment for a total of 10 to 14 days.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Additional discussions with presentation of supporting data are available in related content:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">
          "Acute cellulitis and erysipelas in adults: Treatment", section on 'Duration of antibiotic therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">
          "Acute cellulitis and erysipelas in adults: Treatment", section on 'Monitoring response to therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Severe infection
         </strong>
         – In patients with severe or initially progressive infection, intravenous drugs are transitioned to oral antibiotics once there are signs of clinical improvement and no evidence of systemic toxicity. This usually occurs after 48 to 72 hours. The optimal duration of oral therapy in this setting is not known; in general, five to six days of therapy is appropriate for patients whose condition has improved. Extension of antibiotic therapy (up to 14 days) may be warranted in the setting of severe infection, slow response to therapy, or immunosuppression.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3680522973">
         <span class="h3">
          Minimal or no clinical response
         </span>
         <span class="headingEndMark">
          —
         </span>
         If there is minimal or no clinical improvement on antibiotic treatment within 48 to 72 hours, we evaluate with ultrasound imaging to determine if there is an underlying abscess. If abscess is not present, milk cultures should be obtained to further inform antibiotic selection. We also consider the possibility of a noninfectious process. (See
         <a class="medical medical_review" href="/z/d/html/795.html" rel="external">
          "Primary breast abscess"
         </a>
         and
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H233279742">
         <span class="h2">
          Lactation professionals
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lactation professionals, including lactation consultants, are often involved in early assessment of patients who develop mastitis  (
         <a class="graphic graphic_table graphicRef132669" href="/z/d/graphic/132669.html" rel="external">
          table 5
         </a>
         ). Their role is to provide advice on optimal feeding strategies, to support lactating parents, and to provide education. Their advice may include the use of nonsteroidal anti-inflammatory agents, keeping the area cool, and medical referral of those with signs and symptoms of bacterial mastitis for antibiotics [
         <a href="#rid5">
          5
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4978.html" rel="external">
          "Breastfeeding: Parental education and support", section on 'Programmatic approaches and professional resources'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1036786619">
         <span class="h1">
          BREAST IMPLANTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with breast implants can breastfeed but lower rates of success have been reported compared with individuals without implants (82 versus 88 percent in a meta-analysis of 11 observational studies) [
         <a href="#rid40">
          40
         </a>
         ]. The presence of implanted foreign bodies may predispose to bacterial infection, including lactational mastitis [
         <a href="#rid41">
          41-43
         </a>
         ]. An observational study of over 28,000 postpartum women reported infectious mastitis occurred in 8.3 percent of patients with implants versus 6.6 percent of those without (OR 1.22, 95% CI 1.09-1.35) [
         <a href="#rid44">
          44
         </a>
         ]. However, the absolute rate of infection below 10 percent in both groups was overall reassuring. Patients with breast implants who develop lactational or infectious mastitis receive the same treatment as those without implants. Patients with implants may benefit from antibiotic use until redness and related symptoms are gone or nearly resolved.
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          RECURRENCE
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is no consensus definition of recurrent lactational mastitis. Repeat episodes of lactational mastitis may result from ongoing breastfeeding problems, inability to remediate breastfeeding technique that is leading to incomplete milk drainage, and/or inappropriate or incomplete antibiotic therapy. Repeat episodes of lactational mastitis are treated in the same manner as discussed above. Consultation with a lactation professional may be beneficial to manage underlying causes.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="local">
          'Treatment'
         </a>
         above.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="local">
          'Lactation professionals'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p>
         Patients that have repeated episodes in the same location of the breast and/or do not respond to antibiotic therapy are evaluated for inflammatory breast carcinoma. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H1071766992">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111345.html" rel="external">
          "Society guideline links: Breastfeeding and infant nutrition"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/140833.html" rel="external">
          "Patient education: Mastitis (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/15826.html" rel="external">
          "Patient education: Common breastfeeding problems (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topic (see
         <a class="medical medical_patient" href="/z/d/html/1217.html" rel="external">
          "Patient education: Common breastfeeding problems (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pathogenesis
         </strong>
         – Lactational mastitis is inflammation of the breast tissues associated with breastfeeding. The primary event appears to be ductal narrowing  (
         <a class="graphic graphic_figure graphicRef88523" href="/z/d/graphic/88523.html" rel="external">
          figure 1
         </a>
         ) that leads to poor drainage and subsequent inflammation, edema, and compression of additional milk ducts. Breast milk can contain bacteria; incomplete breast emptying may result in organisms growing and proliferating into infectious mastitis. (See
         <a class="local">
          'Epidemiology and pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microbiology
         </strong>
         – Most episodes of infectious lactational mastitis are caused by
         <em>
          Staphylococcus aureus
         </em>
         or
         <em>
          Streptococcus
         </em>
         species. Methicillin-resistant
         <em>
          S
         </em>
         .
         <em>
          aureus
         </em>
         (MRSA) has become an important pathogen. (See
         <a class="local">
          'Microbiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – Patients with lactational mastitis typically present with a swollen and tender region of the breast, which may also be red in patients with lighter skin tone  (
         <a class="graphic graphic_picture graphicRef126606" href="/z/d/graphic/126606.html" rel="external">
          picture 1
         </a>
         ). Systemic complaints may include myalgia, chills, malaise, and flu-like symptoms. It is most common during the first three months of breastfeeding. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnostic evaluation
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          History and physical examination
         </strong>
         – Lactational mastitis is diagnosed by physical examination confirming a swollen and tender breast in a lactating patient with history of breast pain and/or swelling  (
         <a class="graphic graphic_picture graphicRef126606" href="/z/d/graphic/126606.html" rel="external">
          picture 1
         </a>
         ). Erythema (redness) may or may not be present.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Laboratory evaluation
         </strong>
         – Laboratory tests and imaging studies are not indicated for the diagnosis of lactational mastitis. By contrast, milk and/or blood cultures can be helpful for patients with suspected bacterial infection, infection that does not respond to initial treatment, or patients with evidence of sepsis.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Imaging studies
         </strong>
         – Breast imaging, typically with ultrasound, is useful to exclude abscess in patients who do not respond to treatment within 48 to 72 hours. (See
         <a class="local">
          'Diagnostic evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis –
         </strong>
         The differential diagnosis includes severe breast engorgement, plugged duct, galactocele, breast abscess, and inflammatory breast cancer. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Clinical management
         </strong>
         – All patients with lactational mastitis are counseled on treatment to reduce pain and swelling (eg, nonsteroidal inflammatory agents, cold compresses) and emptying of the breast, ideally via ongoing breastfeeding and/or hand expression. (See
         <a class="local">
          'Clinical management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Antibiotic therapy
         </strong>
         – Management of infectious lactational mastitis includes the above measures plus administration of antibiotic therapy with activity against
         <em>
          S. aureus
         </em>
         . Drug selection is similar to that for cellulitis and other soft tissue infections  (
         <a class="graphic graphic_algorithm graphicRef139109" href="/z/d/graphic/139109.html" rel="external">
          algorithm 1
         </a>
         ), with preference for drugs that are compatible with breastfeeding. (See
         <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">
          "Acute cellulitis and erysipelas in adults: Treatment", section on 'Acute cellulitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Nonsevere infection
         </strong>
         – For patients with nonsevere infectious mastitis and no MRSA risk factors, we suggest treatment with
         <a class="drug drug_general" data-topicid="9349" href="/z/d/drug information/9349.html" rel="external">
          dicloxacillin
         </a>
         , flucloxacillin,
         <strong>
          or
         </strong>
         <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">
          cephalexin
         </a>
         rather than other agents (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). The dosing for each of these drugs is 500 mg orally given four times a day. (See
         <a class="local">
          'Antibiotic selection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         For patients with MRSA risk factors  (
         <a class="graphic graphic_table graphicRef53504" href="/z/d/graphic/53504.html" rel="external">
          table 2
         </a>
         ) or patients unable to tolerate beta-lactams, we suggest treatment with
         <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">
          trimethoprim-sulfamethoxazole
         </a>
         (TMP-SMX)
         <strong>
          or
         </strong>
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         rather than other agents (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Dosing is TMP-SMX one double-strength tablet orally twice daily or clindamycin 450 mg orally three times per day. (See
         <a class="local">
          'Antibiotic selection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Severe infection
         </strong>
         – For patients with evidence of severe infection (eg, fever, hypotension) or those not improving with appropriate oral antibiotics, we suggest treatment with intravenous
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         <strong>
          and
         </strong>
         either
         <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">
          ceftriaxone
         </a>
         <strong>
          or
         </strong>
         <a class="drug drug_general" data-topicid="9777" href="/z/d/drug information/9777.html" rel="external">
          piperacillin-tazobactam
         </a>
         rather than treatment with other agents  (
         <a class="graphic graphic_table graphicRef128911" href="/z/d/graphic/128911.html" rel="external">
          table 4
         </a>
         ) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Inpatient treatment is typically warranted. Subsequent treatment decisions are based on culture results. (See
         <a class="local">
          'Antibiotic selection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Evidence of sepsis
         </strong>
         – The rare patient with infectious lactational mastitis and evidence of sepsis, including hypotension, tachycardia, tachypnea, fever, leukocytosis, and/or evidence of end organ dysfunction, requires immediate evaluation and supportive management, as discussed in detail separately.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         (See
         <a class="medical medical_review" href="/z/d/html/1657.html" rel="external">
          "Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         (See
         <a class="medical medical_review" href="/z/d/html/1613.html" rel="external">
          "Evaluation and management of suspected sepsis and septic shock in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Duration of treatment
         </strong>
         – The optimal duration of antibiotic treatment is not clear and varies, in part, by severity of initial disease and speed of patient response.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Nonsevere infection
         </strong>
         – The general treatment duration for patients receiving oral antibiotics is five to seven days. Patients who do not respond fully may require longer duration of treatment, up to 10 to 14 days.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Severe infection
         </strong>
         – Patients hospitalized with severe infection that warrants intravenous antibiotics are transitioned to oral antibiotics once there are signs of clinical improvement and no evidence of systemic toxicity; this usually occurs after 48 to 72 hours. In general, treatment for five to seven days is reasonable in patients with rapid response to treatment but extended treatment may be required. (See
         <a class="local">
          'Duration of treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects. Obstet Gynecol 2007; 109:479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson E, Woodd SL, Benova L. Incidence of and Risk Factors for Lactational Mastitis: A Systematic Review. J Hum Lact 2020; 36:673.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berens PD. Breast Pain: Engorgement, Nipple Pain, and Mastitis. Clin Obstet Gynecol 2015; 58:902.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stafford I, Hernandez J, Laibl V, et al. Community-acquired methicillin-resistant Staphylococcus aureus among patients with puerperal mastitis requiring hospitalization. Obstet Gynecol 2008; 112:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitchell KB, Johnson HM, Rodríguez JM, et al. Academy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022. Breastfeed Med 2022; 17:360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández L, Pannaraj PS, Rautava S, Rodríguez JM. The Microbiota of the Human Mammary Ecosystem. Front Cell Infect Microbiol 2020; 10:586667.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitoulas LR, Davanzo R. Breast Pumps and Mastitis in Breastfeeding Women: Clarifying the Relationship. Front Pediatr 2022; 10:856353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kvist LJ, Larsson BW, Hall-Lord ML, et al. The role of bacteria in lactational mastitis and some considerations of the use of antibiotic treatment. Int Breastfeed J 2008; 3:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon JM, Khan LR. Treatment of breast infection. BMJ 2011; 342:d396.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomsen AC, Espersen T, Maigaard S. Course and treatment of milk stasis, noninfectious inflammation of the breast, and infectious mastitis in nursing women. Am J Obstet Gynecol 1984; 149:492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amir LH. Breast pain in lactating women--mastitis or something else? Aust Fam Physician 2003; 32:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li D, Li J, Yuan Y, et al. Risk factors and prognosis of acute lactation mastitis developing into a breast abscess: A retrospective longitudinal study in China. PLoS One 2022; 17:e0273967.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiménez E, Arroyo R, Cárdenas N, et al. Mammary candidiasis: A medical condition without scientific evidence? PLoS One 2017; 12:e0181071.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Betts RC, Johnson HM, Eglash A, Mitchell KB. It's Not Yeast: Retrospective Cohort Study of Lactating Women with Persistent Nipple and Breast Pain. Breastfeed Med 2021; 16:318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schoenfeld EM, McKay MP. Mastitis and methicillin-resistant Staphylococcus aureus (MRSA): the calm before the storm? J Emerg Med 2010; 38:e31.
          </a>
         </li>
         <li class="breakAll">
          Department of child and adolescent health and development. Mastitis: Causes and management. World Health Organization 2000. http://whqlibdoc.who.int/hq/2000/WHO_FCH_CAH_00.13.pdf (Accessed on August 17, 2009).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crepinsek MA, Taylor EA, Michener K, Stewart F. Interventions for preventing mastitis after childbirth. Cochrane Database Syst Rev 2020; 9:CD007239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson L, Kynoch K, Kildea S, Lee N. Effectiveness of breast massage for the treatment of women with breastfeeding problems: a systematic review. JBI Database System Rev Implement Rep 2019; 17:1668.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Louis-Jacques AF, Berwick M, Mitchell KB. Risk Factors, Symptoms, and Treatment of Lactational Mastitis. JAMA 2023; 329:588.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spencer JP. Management of mastitis in breastfeeding women. Am Fam Physician 2008; 78:727.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon JM. Breast abscess. Br J Hosp Med (Lond) 2007; 68:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prachniak GK. Common breastfeeding problems. Obstet Gynecol Clin North Am 2002; 29:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berens PD. Prenatal, intrapartum, and postpartum support of the lactating mother. Pediatr Clin North Am 2001; 48:365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kvist LJ, Rydhstroem H. Factors related to breast abscess after delivery: a population-based study. BJOG 2005; 112:1070.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dener C, Inan A. Breast abscesses in lactating women. World J Surg 2003; 27:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Breastfeeding Challenges: ACOG Committee Opinion, Number 820. Obstet Gynecol 2021; 137:e42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hill PD, Humenick SS. The occurrence of breast engorgement. J Hum Lact 1994; 10:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zakarija-Grkovic I, Stewart F. Treatments for breast engorgement during lactation. Cochrane Database Syst Rev 2020; 9:CD006946.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amir LH, Forster D, McLachlan H, Lumley J. Incidence of breast abscess in lactating women: report from an Australian cohort. BJOG 2004; 111:1378.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lepori D. Inflammatory breast disease: The radiologist's role. Diagn Interv Imaging 2015; 96:1045.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sabate JM, Clotet M, Torrubia S, et al. Radiologic evaluation of breast disorders related to pregnancy and lactation. Radiographics 2007; 27 Suppl 1:S101.
          </a>
         </li>
         <li class="breakAll">
          National Health Service (NHS). Mastitis. https://www.nhs.uk/conditions/mastitis/ (Accessed on February 14, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jahanfar S, Ng CJ, Teng CL. Antibiotics for mastitis in breastfeeding women. Cochrane Database Syst Rev 2013; :CD005458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Witt AM, Bolman M, Kredit S, Vanic A. Therapeutic Breast Massage in Lactation for the Management of Engorgement, Plugged Ducts, and Mastitis. J Hum Lact 2016; 32:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ezzo J, Manheimer E, McNeely ML, et al. Manual lymphatic drainage for lymphedema following breast cancer treatment. Cochrane Database Syst Rev 2015; :CD003475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barker M, Adelson P, Peters MDJ, Steen M. Probiotics and human lactational mastitis: A scoping review. Women Birth 2020; 33:e483.
          </a>
         </li>
         <li class="breakAll">
          Drugs and Lactation Database (LactMed) [Internet]. Trimethoprim-Sulfamethoxazole. https://www.ncbi.nlm.nih.gov/books/NBK501289/ (Accessed on January 17, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Long T, Ning Z, Fu B, et al. Maintaining Breastfeeding During the Treatment of Breast Abscesses Is Not Contraindicated. Breastfeed Med 2022; 17:753.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pileri P, Sartani A, Mazzocco MI, et al. Management of Breast Abscess during Breastfeeding. Int J Environ Res Public Health 2022; 19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen J, Zhu XM, Huynh MNQ, McRae M. Breastfeeding Outcome and Complications in Females With Breast Implants: A Systematic Review and Meta-Analysis. Aesthet Surg J 2023; 43:731.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest 1984; 73:1191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 1982; 146:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ELEK SD, CONEN PE. The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. Br J Exp Pathol 1957; 38:573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shalev Ram H, Ram S, Wiser I, et al. Associations between breast implants and postpartum lactational mastitis in breastfeeding women: retrospective study. BJOG 2022; 129:267.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 798 Version 38.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17267864" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32286139" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Incidence of and Risk Factors for Lactational Mastitis: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26512442" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Breast Pain: Engorgement, Nipple Pain, and Mastitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18757649" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Community-acquired methicillin-resistant Staphylococcus aureus among patients with puerperal mastitis requiring hospitalization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35576513" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Academy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33330129" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The Microbiota of the Human Mammary Ecosystem.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35757121" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Breast Pumps and Mastitis in Breastfeeding Women: Clarifying the Relationship.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18394188" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The role of bacteria in lactational mastitis and some considerations of the use of antibiotic treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21317199" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Treatment of breast infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6742017" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Course and treatment of milk stasis, noninfectious inflammation of the breast, and infectious mastitis in nursing women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12666351" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Breast pain in lactating women--mastitis or something else?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36048839" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Risk factors and prognosis of acute lactation mastitis developing into a breast abscess: A retrospective longitudinal study in China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28704470" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Mammary candidiasis: A medical condition without scientific evidence?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33305975" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : It's Not Yeast: Retrospective Cohort Study of Lactating Women with Persistent Nipple and Breast Pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19232875" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Mastitis and methicillin-resistant Staphylococcus aureus (MRSA): the calm before the storm?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19232875" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Mastitis and methicillin-resistant Staphylococcus aureus (MRSA): the calm before the storm?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32987448" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Interventions for preventing mastitis after childbirth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31135656" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Effectiveness of breast massage for the treatment of women with breastfeeding problems: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36701134" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Risk Factors, Symptoms, and Treatment of Lactational Mastitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18819238" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Management of mastitis in breastfeeding women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17639835" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Breast abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11892875" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Common breastfeeding problems.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11339157" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Prenatal, intrapartum, and postpartum support of the lactating mother.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16045520" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Factors related to breast abscess after delivery: a population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12616423" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Breast abscesses in lactating women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33481531" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Breastfeeding Challenges: ACOG Committee Opinion, Number 820.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7619260" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : The occurrence of breast engorgement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32944940" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Treatments for breast engorgement during lactation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15663122" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Incidence of breast abscess in lactating women: report from an Australian cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26372222" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Inflammatory breast disease: The radiologist's role.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18180221" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Radiologic evaluation of breast disorders related to pregnancy and lactation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18180221" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Radiologic evaluation of breast disorders related to pregnancy and lactation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23450563" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Antibiotics for mastitis in breastfeeding women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26644422" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Therapeutic Breast Massage in Lactation for the Management of Engorgement, Plugged Ducts, and Mastitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25994425" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Manual lymphatic drainage for lymphedema following breast cancer treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32146088" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Probiotics and human lactational mastitis: A scoping review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32146088" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Probiotics and human lactational mastitis: A scoping review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36121389" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Maintaining Breastfeeding During the Treatment of Breast Abscesses Is Not Contraindicated.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35565158" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Management of Breast Abscess during Breastfeeding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36752943" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Breastfeeding Outcome and Complications in Females With Breast Implants: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6323536" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Pathogenesis of foreign body infection. Evidence for a local granulocyte defect.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7119479" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Pathogenesis of foreign body infection: description and characteristics of an animal model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13499821" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34486797" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Associations between breast implants and postpartum lactational mastitis in breastfeeding women: retrospective study.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
